The CFO Show · 2025-02-25 · 44 min
Intellectual property (IP) is revolutionizing how companies build value. For many businesses, the key to sustainable growth lies not in their balance sheet, but in the ideas they own. Erin-Michael Gill , founder of M&A firm Genaesis, LLC , and Chairman of a Federal Advisory Committee on Intellectual Property and Trade, shares his expertise in this episode. With over $1.2 billion in M&A and capital formation investments under his advisory, Gill is consistently recognized as one of the world's leading IP strategists. Erin-Michael delves into the intersection of IP strategy, innovation, and deal-making. He discusses how CFOs can unlock the full potential of their IP portfolios to fuel growth, attract investors, and drive success in M&A transactions. Discover why IP should be at the forefront of your business strategy and learn practical approaches to developing and managing IP assets. Discussed in This Episode: The pivotal role of IP and intangible assets in driving company valuation and growth, with a focus on M&A contexts. Why many businesses overlook their potential to monetize IP and other intangible assets.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Architecting 100x Growth: A “How-To” From Legends Dan Sullivan and John BowenThe Diamond Podcast for Financial Advisors · on Intellectual Property74 / 100
Can AI Agents be held Accountable?The Enterprise AI Show · on CFO
239. PE Backed: The CFO’s Balancing Act Between Growth and Governance with Ian PughCFO 4.0 Podcast · on CFO
Private Equity's Co-Pilot: The Strategic Role of the CFOBest But Never Final: Private Equity's Pursuit of Excellence · on CFO
Global Growth, Integration and AI: Lessons from Grant Thornton’s CEO70 / 100
How CFOs Build Resilient Careers: Lessons from Banking, M&A and GoFundMe73 / 100
Business Agility in Finance: How CFOs Can Thrive in Volatility and Uncertainty57 / 100
ERP Transformation Strategy: How CFOs Avoid Failure, Hidden Costs and Legacy Risk80 / 100
Managing Costs, Complexity, and Change in Healthcare Finance